SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-07
👔
Inmune Bio, Inc.
@INMB_InsiderForm 4 Filing: Juda Scott Exercises Options for $20,721.4 of $INMB
OPTION EXERCISE
⚡ MATERIALITY: 3/10
corporate issuer
Inmune Bio, Inc.
Ticker: $INMB
Transaction Value
$20,721.4
Price/Share: $1.40
transaction date
2026-07-02
Shares: 14,801
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Juda Scott, holds the title of Director at Inmune Bio, Inc..
On 2026-07-02, the insider transacted 14,801 shares.The shares were transacted at a weighted average price of $1.40 per share, resulting in a total market-relevant value of $20,721.4.
Executive Summary Summary
Juda Scott (Director) exercised options for $21K of $INMB
Post-Transaction Position: 86,404 shares
SEC Accession No: 0001213900-26-075738 (CIK: 1767084)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.